Rasagiline Tablets 0.5 mg (Rasagiline Mesilate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended starting dose for patients taking levodopa is 0.5mg once daily. If well tolerated but an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be used by patients who are allergic to its active ingredient or any other components. Moreover, it may cause serious side effects when taken together with other MAO inhibitors or certain pain relievers and cold medications; hence, patients taking such medications should not use this product. Patients with moderate to severe liver dysfunction should not take this medication, and those with mild liver impairment should use caution when taking it. Various side effects such as headaches, dizziness, nausea, insomnia, and skin rashes may occur during treatment; if symptoms are severe or persist, consultation with a physician is recommended. This medication is intended for Parkinson's disease patients, and attention should be paid to any mental symptoms such as hallucinations or depression, as changes in mental status should be closely monitored. Additionally, during treatment, blood pressure changes, especially severe issues such as hypotension or hypertension crises, may occur; thus, regular blood pressure monitoring is necessary. When used with dopamine-related medications, drowsiness or sudden sleep may occur, necessitating care when driving or operating machinery. During pregnancy or breastfeeding, the safety of this medication has not been established, and consultation with a physician prior to use is a must. The safety and efficacy of this medication have not been proven in children, and no special dosage adjustments are needed for the elderly. In case of overdose, symptoms such as severe blood pressure elevation, confusion, and seizures may present, warranting immediate medical attention for appropriate treatment. This medication should be stored in a cool place, protected from direct sunlight, and secured out of reach of children.

• influenza
• skin cancer
• leukopenia
• allergies
• decreased appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and kept at a cool room temperature between 1 and 25 degrees Celsius. Proper storage helps maintain its efficacy and safety.

Appearance

White round tablet engraved with “MI” on one side and “L” on the other

Package unit

30 tablets/bottle